Business Insider

Persica Pharmaceuticals' Positive Clinical Data for PP353 Treatment of Chronic Low Back Pain Published in The Lancet's eClinicalMedicine

Trial demonstrated that PP353 delivers clinically meaningful and durable reduction in pain and disability in patients with chronic Low Back Pain and Modic Type 1 changes PP353 has the potential to ...
Business Insider

Persica Pharmaceutical’s PP353 Phase 1b Data Selected for Oral Presentation at the American Society of Interventional Pain Physicians (ASIPP) 2026 Annual Meeting

ASIPP presentation follows publication of positive data from PP353 Phase 1b Modic Trial in The Lancet’s eClinicalMedicine London, UK, 19 March 2026 - Persica Pharmaceuticals Limited (Persica), a ...
Medscape

Pro-fibrotic phenotype of bone marrow stromal cells in Modic type 1 changes.

Heggli I; Epprecht S; Juengel A; Schuepbach R; Farshad-Amacker N; German C; Mengis T; Herger N; Straumann L; Baumgartner S; Betz M; Spirig JM; Wanivenhaus F; Ulrich N; Bellut D; Brunner F; Farshad M; ...